|
Delayed
London S.E.
15:24:05 15/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1155 GBX | +5.00% |
|
+10.00% | -46.28% |
| 10-14 | WINNERS & LOSERS: 80 Mile up as US president plots Greenland exploring | AN |
| 09-03 | Futura Medical's fundraise and formal sale process | AN |
| Market Cap | 17.48M 19.44M 16.31M 14.79M 27.76M 1.85B 27.93M 196M 76.44M 960M 72.99M 71.41M 3.09B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 21.11M 23.48M 19.7M 17.86M 33.53M 2.23B 33.74M 236M 92.33M 1.16B 88.17M 86.26M 3.73B | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | - |
| Free-Float |
90.64% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| OBD | Delayed | |
OTC Markets
| OXBOF | Delayed | |
|
Börse Stuttgart
| LMQ | Delayed | |
|
Deutsche Boerse AG
| LMQ | Delayed |
| 1 day | +5.00% | ||
| 1 week | +10.00% | ||
| Current month | -4.55% | ||
| 1 month | +0.43% | ||
| 3 months | +10.00% | ||
| 6 months | -40.77% | ||
| Current year | -46.28% |
| 1 week | 0.09 |  | 0.12 |
| 1 month | 0.09 | | 0.12 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.55 |
| 3 years | 0.08 | | 41.9 |
| 5 years | 0.08 | | 53.6 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 08/06/2007 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 15/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 08/06/2007 | |
Paul Stockdale
BRD | Director/Board Member | - | 15/09/2017 |
David Holbrook
BRD | Director/Board Member | 65 | 05/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/11/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.00% | +10.00% | -76.90% | -99.67% | 19.44M | |
| +4.51% | +7.62% | +52.28% | +104.12% | 1,077B | |
| +2.14% | +1.27% | +35.87% | +64.89% | 612B | |
| +2.48% | +6.13% | +27.80% | +96.37% | 501B | |
| +1.86% | +5.65% | +78.85% | +44.45% | 364B | |
| +1.79% | +7.20% | +33.09% | +49.95% | 353B | |
| +2.02% | +6.49% | +20.49% | +43.76% | 278B | |
| +3.25% | +7.05% | +0.68% | +16.02% | 251B | |
| +2.93% | +7.96% | +47.95% | +53.33% | 230B | |
| +3.14% | +7.55% | +33.73% | +99.75% | 190B | |
| Average | +2.90% | +1.68% | +25.38% | +47.30% | 385.65B | |
| Weighted average by Cap. | +2.95% | +1.58% | +40.42% | +72.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.89M 2.1M 1.76M 1.6M 3M 200M 3.02M 21.18M 8.27M 104M 7.9M 7.73M 334M | - |
| Net income | - | - |
| Net Debt | 3.63M 4.04M 3.39M 3.07M 5.77M 385M 5.8M 40.69M 15.89M 200M 15.17M 14.84M 642M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | GBX 0.1155 | +5.00% | 24,068,209 |
| 14/10/26 | GBX 0.1100 | +10.00% | 66,226,671 |
| 13/10/26 | GBX 0.1000 | +5.26% | 74,000,723 |
| 12/10/26 | GBX 0.0950 | -5.00% | 14,701,115 |
| 09/10/26 | GBX 0.1000 | -4.76% | 14,219,782 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001100GBP
Average target price
0.003000GBP
Spread / Average Target
+172.73%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
